Randomized phase II study of afatinib alone or in combination with vinorelbine versus investigator’s choice of treatment in patients with HER2-positive breast cancer with pro-gressive brain metastases after trastuzumab or lapatinib based therapy

Cancer type: Breast cancer

Phase: II

Principal Investigator: Bono Petri

Country: FI

Keywords: Finland

Status: Inclusion completed

Link to